Log In
BCIQ
Print this Print this
 

recombination adsorbed hepatitis B vaccine (Bimmugen)

  Manage Alerts
Collapse Summary General Information
Company Kaketsuken
DescriptionYeast-based vaccine against hepatitis B
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B infection via hepatitis B s antigen (HBsAg)-positive or hepatitis B e antigen (HBeAg)-positive contaminated blood; Prevent maternally transmitted hepatitis B; Prophylaxis against hepatitis B virus (HBV)
Regulatory Designation
PartnerDaiichi Sankyo Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/28/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today